Colin has thirty years of experience as a public and private life science company Chairman, Executive Chairman, Board Member, CEO, and entrepreneur with leadership experience across the R&D-commercial continuum in therapeutics, diagnostics, and medical devices. He has led multi-billion-dollar, midsized, small, and start-up life science companies in the USA, Canada, United Kingdom/Ireland, and Israel. He began his career in pharmaceutical marketing & sales ultimately becoming President & CEO of Bayer Pharmaceuticals North America, following which he co-founded and was CEO of Optherion Inc, a venture-backed biotechnology company. Subsequently, he was Executive Chairman of Ivenix Inc, a venture-backed medical device company, Board Member, President & CEO of Bioblast Pharma Ltd, a public biotechnology company, and founder of iSci Management, a strategic advisory firm. Colin has a B.Sc. in Zoology and Microbiology from the University of Toronto, an M.B.A. from the Ivy School of Business, Western University, and his Canadian Securities Certificate.